Cancer mortality could fall by as much as 36% by 2043, according to Swiss Re, but rising incidence could mean increased morbidity and complexity for life and health insurance.
The reinsurer said that population aging is expected to increase cancer incidence, with those over 50 significantly more likely to develop cancer. An aging population, combined with increasing survival rates, also means that cancer is likely to become a long-term health challenge, according to the reinsurer. Swiss Re said the standardised mortality rate for all cancers in 2023 was 242 per 100,000. For the five cancers analysed (breast, colorectal, lung, pancreatic and prostate), the rate was 121 per 100,000 According to the report, Swiss Re projects this could fall to 78-104 by 204...
To continue reading this article...
Join COVER for free
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.




